Login Register
English
0

Cart

$ 0

VHL Polyclonal Antibody

VHL Polyclonal Antibody

Views(4) Publications(0) Catalog no(ABP60891)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name VHL Polyclonal Antibody
Immunogen Synthesized peptide derived from part region of human VHL protein at amino acid sequence of 1-50
Host Rabbit
Reactivity Human,Rat,Mouse,
Applications IHC,IF,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-200;ELISA 1:10000-20000;IF 1:50-200
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative Von Hippel-Lindau disease tumor suppressor; Protein G7; pVHL

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 19-24kD
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of VHL is the basis of familial inheritance of VHL syndrome. The protein encoded by VHL is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity. This protein is involved in the ubiquitination and degradation of hypoxia-inducible-factor (HIF), which is a transcription factor that plays a central role in the regulation of gene expression by oxygen. RNA polymerase II subunit POLR2G/RPB7 is also reported to be a target of this protein. Alternatively spliced transcript variants encoding distinct isoforms have been observed.
Gene ID 7428
Alternative Von Hippel-Lindau disease tumor suppressor; Protein G7; pVHL
Others The antibody detects endogenous levels of VHL
Accession P40337

Image & description

Fig.1. Immunohistochemical analysis of paraffin-embedded human-colon, antibody was diluted at 1:200.

Fig.1. Immunohistochemical analysis of paraffin-embedded human-colon, antibody was diluted at 1:200.

Fig.2. Immunohistochemical analysis of paraffin-embedded human-colon, antibody was diluted at 1:200.

Fig.2. Immunohistochemical analysis of paraffin-embedded human-colon, antibody was diluted at 1:200.

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “VHL Polyclonal Antibody”